Get started
Award

20150070

Funded outputs count: 5
Funder award ID: 20150070
OpenAlex ID: G7547549784
A ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) Cells
2022 · Amineh Ghaderi, Wen Zhong, et al. · Pharmaceutics · 22
PDF
ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells
2020 · Amineh Ghaderi, Amir Hossein Daneshmanesh, et al. · Biomedicines · 40
PDF
A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib
2018 · Amir Hossein Daneshmanesh, Mohammad Hojjat-Farsangi, et al. · PLoS ONE · 46
PDF
First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells
2018 · M. Hojjat-Farsangi, A. H. Daneshmanesh, et al. · Leukemia · 61
PDF
Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia
2017 · Lotta Hansson, Anna Asklid, et al. · Annals of Hematology · 14
PDF
Year
Topic